HomeAI · summaries
Storia in 2 fonti
EXCLUSIVE: Immunic Appoints Former Genentech Exec Erik Lundgren As CEO - Immunic (NASDAQ:IMUX)
Immunic (IMUX) stock rises premarket to $13.14 as the company names former Genentech executive Erik Lundgren as CEO. See how his historic multiple sclerosis drug launch experience accelerates Immunic's Phase 3 trials in 2026.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
benzinga.com
EXCLUSIVE: Immunic Appoints Former Genentech Exec Erik Lundgren As CEO - Immunic (NASDAQ:IMUX)
Immunic (IMUX) stock rises premarket to $13.14 as the company names former Genentech executive Erik Lundgren as CEO. See how his historic multiple sclerosis drug launch experience…
- ·
morningstar.com
Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer
Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer